Back to News
Market Impact: 0.65

Analysts revise AMD stock price target

AMDPIPRBCS
Corporate EarningsCorporate Guidance & OutlookAnalyst EstimatesAnalyst InsightsArtificial IntelligenceTechnology & InnovationSanctions & Export ControlsCompany Fundamentals
Analysts revise AMD stock price target

Advanced Micro Devices (AMD) reported mixed Q2 2025 results, with revenue up 32% to $7.7 billion but EPS declining to $0.48, leading to an initial 9% stock decline. Despite this, analysts like Piper Sandler and Barclays raised price targets to $190-$200, citing strong data center growth and AI demand, which aligns with AMD's robust Q3 FY2025 revenue forecast of $8.7 billion and projected 54% gross margin, driven by its MI350 AI accelerators. While the average 12-month price target still implies a 7.54% downside, the company's long-term outlook is underpinned by these high-growth segments, though potential revenue from China's Instinct MI308 shipments remains contingent on U.S. government approval.

Analysis

Advanced Micro Devices presented a mixed financial picture for Q2 2025, characterized by strong top-line growth but deteriorating profitability. The company reported a 32% year-over-year revenue increase to $7.7 billion, yet earnings per share fell to $0.48 from $0.69 in the prior year, triggering an initial stock decline of over 9%. Despite this EPS miss, forward-looking sentiment from both the company and certain analysts is optimistic, driven by secular growth trends. AMD management forecasts robust Q3 revenue of approximately $8.7 billion, representing 28% year-over-year growth, and expects non-GAAP gross margins to recover to around 54%. This positive outlook is echoed by analysts at Piper Sandler and Barclays, who raised their price targets to $190 and $200, respectively, citing strong demand for data center and AI products. However, significant market uncertainty persists, as evidenced by the wide dispersion of analyst targets ($111 to $210) and an average price target of $161.16, which implies a 7.54% downside from current levels. A key variable remains the pending U.S. government approval for Instinct MI308 shipments to China, which is excluded from guidance and represents a potential geopolitical risk or upside catalyst.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.